Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer

被引：0
|
作者：
Desai, Neil Bipinchandra
Folkert, Michael Ryan
Leiker, Andrew
Yan, Yulong
Costa, Daniel N.
Dess, Robert Timothy
Spratt, Daniel Eidelberg
Garant, Aurelie
Hannan, Raquibul
Timmerman, Robert D.
机构：
[1] UT Southwestern, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS381
引用
收藏
页数：2
相关论文
共 18 条
  • [1] Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial
    Leiker, A. J.
    Rezaeian, N. Hassan
    Laine, A. M.
    Hannan, R.
    Folkert, M. R.
    Timmerman, R. D.
    Jia, X.
    Desai, N. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E125 - E125
  • [2] Rectal Spacer Facilitates Neurovascular Bundle Sparing Stereotactic Body Radiotherapy for Erectile Function Preservation in Prostate Cancer
    Mayeda, M.
    Hwang, M.
    Shaish, H.
    Elliston, C.
    Wenske, S.
    Deutsch, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E264 - E264
  • [3] Predicting Neurovascular Sparing in Function-Preserving Stereotactic Ablative Radiotherapy (SAbR) of Prostate Cancer: An Innovative Implementation of Deep Learning Technique
    Rezaeian, N. Hassan
    Gonzalez, Y.
    Leiker, A.
    Laine, A.
    Hannan, R.
    Folkert, M.
    Timmerman, R.
    Desai, N.
    Jia, X.
    MEDICAL PHYSICS, 2018, 45 (06) : E191 - E191
  • [4] Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function
    Hwang, Mark E.
    Mayeda, Mark
    Shaish, Hiram
    Elliston, Carl D.
    Spina, Catherine S.
    Wenske, Sven
    Deutsch, Israel
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1119):
  • [5] A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
    Wolfe, Sydney
    Diven, Marshall A.
    Marciscano, Ariel E.
    Zhou, Xi Kathy
    Kishan, A. U.
    Steinberg, M. L.
    Miccio, Joseph A.
    Camilleri, Philip
    Nagar, Himanshu
    BMC CANCER, 2023, 23 (01)
  • [6] A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
    Sydney Wolfe
    Marshall A. Diven
    Ariel E. Marciscano
    Xi Kathy Zhou
    A. U. Kishan
    M. L. Steinberg
    Joseph A. Miccio
    Philip Camilleri
    Himanshu Nagar
    BMC Cancer, 23
  • [7] Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial
    Zapatero, Almudena
    Castro, Pablo
    Roch, Maria
    Carnero, Pablo Rodriguez
    Carroceda, Sara
    Rosciupchin, Alexandra Elena Stoica
    Hernandez, Sergio Honorato
    Cogorno, Leopoldo
    Iturriaga, Alfonso Gomez
    Garcia, David Buchser
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [8] Urethra-Sparing Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Dosimetric Results From a Prospective Multicenter Randomized Phase 2 Trial
    Zilli, T.
    Tsvang, L.
    Symon, Z.
    Abacioglu, U.
    Bruynzeel, A.
    Rouzaud, M.
    Dubouloz, A.
    Pampallona, S.
    Oliveira, A.
    Minn, H.
    Ozen, Z.
    Perez-Moreno, J.
    Sanchez Saugar, E.
    Jorcano, S.
    Escude, L.
    Miralbell, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S900 - S900
  • [9] The STAMPEDE2 stereotactic ablative body radiotherapy (SABR) trial: A phase III, randomised, open-label trial in patients with newly diagnosed oligometastatic prostate cancer (PC) starting androgen deprivation therapy (ADT)
    Abdel-Aty, H.
    Amos, C. L.
    Brown, L. C.
    Yogeswaran, Y.
    Niem, P.
    Dutey-Magni, P.
    Kasivisvanathan, V.
    Bennett, R.
    Clarke, N.
    Sachdeva, A.
    Cross, W.
    Farrelly, L.
    Matheson, D.
    Peedell, C.
    Diez, P.
    Naismith, O.
    Parmar, M. K.
    Attard, G.
    van As, N.
    James, N. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S999 - S999
  • [10] Randomized Phase II Trial Evaluation of Erectile Function after Attempted Unilateral Cavernous Nerve-Sparing Retropubic Radical Prostatectomy With Versus Without Unilateral Sural Nerve Grafting for Clinically Localized Prostate Cancer
    Davis, John W.
    Chang, David W.
    Chevray, Pierre
    Wang, Run
    Shen, Yu
    Wen, Sijin
    Pettaway, Curtis A.
    Pisters, Louis L.
    Swanson, David A.
    Madsen, Lydia T.
    Huber, Nelda
    Troncoso, Patricia
    Babaian, R. Joseph
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2009, 55 (05) : 1135 - 1143
12